improvement in glucose tolerance and reduction in insulin secretion observed following prolonged cb-154 treatment in acromegalic patients are probably due to a simultaneous inhibition of gh secretion or to other peripheral effects of bromocriptine .
C0001206
acromegalic
C0006230
bromocriptine